Document ID: FDA-2020-D-1137-0017
Agency: fda
Document Type: Notice
Title: Investigational COVID–19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction
Posted Date: 2020-10-07T04:00Z

[Federal Register Volume 85, Number 195 (Wednesday, October 7, 2020)]
[Notices]
[Page 63277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22142]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-D-1137]

Investigational COVID-19 Convalescent Plasma; Guidance for 
Industry; Withdrawal of Guidance; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that published in the Federal Register of September 21, 2020. The 
document announced the withdrawal of a final guidance for industry 
entitled ``Investigational COVID-19 Convalescent Plasma,'' which was 
issued in April 2020 and updated in May 2020. FDA withdrew the guidance 
because the Agency issued a new guidance for industry of the same 
title. The document was published with the incorrect docket number for 
the guidance for industry that was withdrawn. This document corrects 
that error.

FOR FURTHER INFORMATION CONTACT: Shruti Modi, Center for Biologics 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION: 

Correction

    In the Federal Register of September 18, 2020 (85 FR 593120), 
appearing on page 59320 in FR Doc. 2020-20801, the following correction 
is made:
    On page 59320, in the third column, the Docket No. ``FDA-2020-D-
1825'' is corrected to read ``FDA-2020-D-1137.''

    Dated: October 1, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-22142 Filed 10-6-20; 8:45 am]
BILLING CODE 4164-01-P